About
Accunome develops advanced automated nucleic acid testing instruments and reagents for life science diagnostics, focusing on early diagnosis and screening of infectious diseases through multi-target real-time PCR technology.
Explore Accunome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.